Theophylline Tablet, Extended Release
Product Images NDC 68462-721

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 68462-721). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl300mg100.jpg (Lbl300mg100)

Theophylline Extended-Release Tablets 300 mg in oral tablet form. The label shows a package containing 100 tablets, manufactured by Glenmark Pharmaceuticals Inc., USA. The label includes the NDC number 68462-721-01 and storage instructions specifying temperature ranges for preservation.*

FDA Label Image

Lbl450mg100.jpg (Lbl450mg100)

Theophylline Extended-Release Tablets 450 mg label showing 100 tablets in the package. The label includes the NDC 68462-722-01, Glenmark logo, storage instructions (20°C to 25°C, excursions permitted to 15°C to 30°C), and manufacturer details: Glenmark Pharmaceuticals Inc., USA. The tablets are uncoated and contain theophylline anhydrous.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of the active ingredient Theophylline, showing its molecular arrangement with nitrogen, oxygen, carbon, and hydrogen atoms represented.*

FDA Label Image

Glenmark-logo (Glenmark Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.